FQP-82195-38666
2 vaccinations
15 coded responses
23 check-ins
15 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 959 / CA
- Registered
- 2021-02-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-19
Dose 1 — Pfizer-BioNTech
-
2021-02-20
Registered in v-safe
-
2021-02-20
Survey response — days 1–6 daily, dose 1MedDRA: Muscular weakness — Feeling: FairFree text: Weakness behind right knee, leg collapsesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-21
Survey response — days 1–6 daily, dose 1MedDRA: Asthenia, Loss of personal independence in daily activities, Muscular weakness — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Collapsing right leg behind the knee, moderate difficulty doing daily activities because of unpredictabilityMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-22
Survey response — days 1–6 daily, dose 1MedDRA: Pre-existing condition improved — Feeling: GoodFree text: Collapsing right knee is improved from moderate to mild.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-23
Survey response — days 1–6 daily, dose 1MedDRA: Asthenia — Feeling: GoodFree text: Knee joint weakness mild, no pain or swellingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-24
Survey response — days 1–6 daily, dose 1MedDRA: Muscular weakness — Feeling: GoodFree text: Joint weakness, right knee joint, mildMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-25
Survey response — days 1–6 daily, dose 1MedDRA: Asthenia — Feeling: GoodFree text: Right knee weakness, mildMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-26
Survey response — day 7, dose 1MedDRA: Muscular weakness — Feeling: GoodFree text: Right knee muscle weakness, mildMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-05
-
2021-03-12
Dose 2 — Pfizer-BioNTech
-
2021-03-13
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite — Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Loss of appetite, moderateMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-14
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite — Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Loss of appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Itching · Fatigue or tiredness, NauseaAdult check-in
-
2021-03-16
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Itching · Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-17
- 2021-03-18
-
2021-03-19
Health check-in — day 7, dose 2Feeling: Fair · Headache, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-26
-
2021-04-02
Survey response — day 21, dose 2MedDRA: Arthralgia — Feeling: FairFree text: Right knee pain, moderateMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-09
-
2021-04-16
Survey response — day 35, dose 2MedDRA: Arthralgia, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Knees hurting, moderate. It has been coming and going since the first vaccine, not before. · Healthcare visit (other): Scheduled acupunctureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Report sent to call center — day 35, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-23
Survey response — day 42, dose 2MedDRA: Acupuncture, Inflammation, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Inflamed right knee · Healthcare visit (other): AcupunctureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-23
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-06-11
Survey response — 3 months, dose 2MedDRA: Arthralgia, Inflammation, Muscular weakness — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Inflammation mostly in knees, pain, muscle weakness in knees · Healthcare visit (other): Blood test for inflammatory markers and also acupunctureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-11
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-18
- 2021-09-10
-
2022-03-14
Survey response — 12 months, dose 2MedDRA: Arthritis, C-reactive protein increased, Systemic lupus erythematosus disease activity inde, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Inflammation in joints, knees and hips, CRP number high, first time positive for lupus · Healthcare visit (other): Lab blood testsMedDRA releases: 2024-11 · check-in free text available
-
2022-03-14
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-03-16
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-19 | Pfizer-BioNTech | |
| 2 | 2021-03-12 | Pfizer-BioNTech |
Call center
4 call center cases
4 successful
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Weakness behind right knee, leg collapses
Systemic reaction (other): Collapsing right leg behind the knee, moderate difficulty doing daily activities because of unpredictability
Systemic reaction (other): Collapsing right knee is improved from moderate to mild.
Systemic reaction (other): Knee joint weakness mild, no pain or swelling
Systemic reaction (other): Joint weakness, right knee joint, mild
Systemic reaction (other): Right knee weakness, mild
Release 4 — day 7, dose 1
Systemic reaction (other): Right knee muscle weakness, mild
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Loss of appetite, moderate
Systemic reaction (other): Loss of appetite
Systemic reaction (other): Dizziness
Release 6 — day 21, dose 2
Symptoms: Right knee pain, moderate
Release 7 — day 35, dose 2
Symptoms: Knees hurting, moderate. It has been coming and going since the first vaccine, not before.
Healthcare visit (other): Scheduled acupuncture
Release 7 — day 42, dose 2
Release 9 — 3 months, dose 2
Symptoms: Inflammation mostly in knees, pain, muscle weakness in knees
Healthcare visit (other): Blood test for inflammatory markers and also acupuncture
Release 11 — 12 months, dose 2
Symptoms: Inflammation in joints, knees and hips, CRP number high, first time positive for lupus
Healthcare visit (other): Lab blood tests
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Acupuncture | ✓ | ✓ | ✓ |
| HCVO | Inflammation | ✓ | ✓ | ✓ |
| HCVO | Office visit | ✓ | ✓ | ✓ |
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Arthritis | · | · | ✓ |
| SD | C-reactive protein increased | · | · | ✓ |
| SD | Inflammation | ✓ | ✓ | ✓ |
| SD | Muscular weakness | ✓ | ✓ | ✓ |
| SD | Systemic lupus erythematosus disease activity inde | · | · | ✓ |
| SRO | Asthenia | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Loss of personal independence in daily activities | ✓ | ✓ | ✓ |
| SRO | Muscular weakness | ✓ | ✓ | ✓ |
| SRO | Pre-existing condition improved | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release